Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 102

BillFederalSenateIn Committee
A bill to significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.
About This Bill
Committee
Latest Action · January 10, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
January 10, 2019
Cosponsors (6)
6D 0R
View PDF ↗
SummaryFull TextCommentsAnnotations

Annotations on Text

0 annotations · Highlight text on the Summary or Full Text tab to add one
No annotations yet. Highlight a passage of the text to add one.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.